Dr R. Katie Morris MBChB, PhD, MRCOG

Dr R. Katie Morris

Institute of Applied Health Research
Reader in Maternal Fetal Medicine

Contact details

Address
Academic Department of Obstetrics & Gynaecology
Academic Floor, Third Floor
Birmingham Women's Foundation Trust
Edgbaston
Birmingham
B15 2TG

Katie’s research aims to improve the care for women with multiple pregnancies, fetal anomalies, growth restriction, reducing infection in maternity and prevention of preterm birth, employing prognostic and diagnostic research, modelling, systematic reviews and trials.

Qualifications

  • Senior Clinical Lecturer Maternal Fetal Medicine
  • PhD Obstetrics and Gynaecology University of Birmingham 2011
  • Member of the Royal College of Obstetricians and Gynaecologists (MRCOG) 2003
  • MBChB Hons University of Liverpool 1998

Biography

Dr Morris was appointed as an Honorary Consultant and Senior Lecturer in Maternal and Fetal Medicine at the University of Birmingham (and Birmingham Women’s NHS Foundation Trust) in January 2015.

She qualified from University of Liverpool in 1998 and then performed house jobs and specialist training within the East Midlands Deanery. In 2005 she came to Birmingham to commence her research and in 2008 commenced an MRC Clinical Research Training Fellowship. This led to the award of her PhD from the University of Birmingham in 2011.

Following her period in research, Dr Morris returned to clinical training as an NIHR Clinical Lecturer in Maternal Fetal medicine at the University of Birmingham/Birmingham Women’s Hospital NHS Foundation Trust. In 2014 she obtained her CCT in Obstetrics and Gynaecology and subspecialty accreditation in Maternal and Fetal Medicine from the Royal College of Obstetricians and Gynaecologists.

 Her current role is as a member of a team of seven accredited consultant subspecialists providing regional and supra-regional care for pregnant women with fetal medicine problems at the West Midlands Fetal Medicine Centre which is situated within the Birmingham Women’s NHS Foundation Trust. Her clinical expertise relates to prenatal diagnosis, the diagnosis of fetal anomalies, conditions requiring fetal therapy including complications of monochorionic twins and intrauterine growth restriction and high risk obstetrics including maternal cardiac disease and preterm birth. Her research relates to her areas of clinical expertise and employs diverse methodologies including prognostic modelling, test accuracy research, epidemiology studies, randomised controlled trials, systematic reviews and meta-analyses. This research is funded from research councils and charities including MRC, HTA, RfPB, Wellbeing of Women, British Maternal and Fetal Medicine Society, Twins and Multiple Births Association, Mary Crosse Foundation and Richard and Jack Wiseman Trust.

Teaching

Dr Morris provides undergraduate teaching for the following modules and is a personal mentor for the MBChB programme:

  • Second year MBChB Reproduction, Genes and Development Module
  • Second year MBChB – Fetal Medicine Personal Interest Project
  • Fifth year MBChB:

-       Obstetrics and Gynaecology academic in days and ward based teaching on attachment

-       Clinical Communication across the patient journey module

Dr Morris also provides postgraduate teaching for Obstetrics and Gynaecology and Maternal Fetal medicine. She is also a Senior Clinical examiner for the fifth year MBChB programme.

Postgraduate supervision

  • Supervision of PhD and Mres students.
  • Supervision of non-clinical Masters and intercalating students.
  • Supervision of Clinical PhD students.
  • Supervision of Advanced Specialist training in Maternal and Fetal Medicine

Research

Dr Morris’s research interests are fetal growth restriction, prognostic and diagnostic research in Obstetrics, complications of multiple pregnancy, invasive therapies in fetal medicine, the role of folic acid supplementation in pregnancy, prevention of preterm birth and reducing infections morbidity and mortality in obstetrics. Her research involves systematic reviews and meta-analysis, prognostic modelling, randomised controlled trials of therapies and cohort and epidemiology studies. Current research grants are “OMMIT study – prediction of adverse outcome in monochorionic twins.”; “QUIDS – Quantitative Fibronectin to help Decision-making in women with Symptoms of Preterm Labour”, “Epigenetic and metabolomics in small for gestational fetuses related to folic acid supplementation”, “Chlorhexidine Vaginal Preparation versus Standard Treatment at Caesarean Section to Reduce Endometritis and Prevent Sepsis - A Feasibility Study (The PREPS Trial) (CI)” and C-STICH and C-STICH 2 (CI) randomised controlled trials investigating cervical cerclage in the prevention of preterm birth.

Other activities

Dr Morris is an Executive member and Trustee of the British Maternal Fetal Medicine Society, is a peer reviewer for international journals and major grant funding bodies including the MRC and HTA. She is a member of the RfPB West Midlands panel. She is lead and developer and author of national guidelines for fetal growth restriction for the RCOG and a member of the STARD group (Standards for Reporting of Diagnostic Accuracy). Dr Morris is the Clinical Specialty Lead for Reproductive Health and Childbirth for the West Midlands.

 She has charitable connections with:

  •  Wellbeing of Women (Research into Women’s Health).
  •  Richard & Jack Wiseman Trust (Research into complications of Twins).
  •  TAMBA
  •  Miscarriage Association
  •  Tommy’s

 She has developed a PPI group in maternity in West Midlands providing input into clinical research and patient experience at her local Trust.

Publications

Selected recent publications:

Dr Morris has over 60 publications with an h-index of 21 and RG score of 34.

 ORCID ID http://orcid.org/0000-0003-1247-429X

 Scopus : https://www.scopus.com/authid/detail.uri?authorId=16053411900

 All cited publications on pubmed Morris RK (https://www.ncbi.nlm.nih.gov/pubmed/?term=Morris%20RK%5BAuthor%5D&cauthor=true&cauthor_uid=20584634

The prediction, diagnosis and management of complications in monochorionic twin pregnancies: the OMMIT (Optimal Management of Monochorionic Twins) study. Mackie FL, Morris RK, Kilby MD. BMC Pregnancy Childbirth. 2017 May 26;17(1):153. doi: 10.1186/s12884-017-1335-3.

 Association of serum PAPP-A levels in first trimester with small for gestational age and adverse pregnancy outcomes: systematic review and meta-analysis. Morris RK, Bilagi A, Devani P, Kilby MD. Prenat Diagn. 2017 Mar;37(3):253-265. doi: 10.1002/pd.5001. Epub 2017 Feb 17. Review.

 Carbohydrate and fatty acid perturbations in the amniotic fluid of the recipient twin of pregnancies complicated by twin-twin transfusion syndrome in relation to treatment and fetal cardiovascular risk.Dunn WB, Allwood JW, Van Mieghem T, Morris RK, Mackie FL, Fox CE, Kilby MD.Placenta. 2016 Aug;44:6-12. doi: 10.1016/j.placenta.2016.05.012. Epub 2016 May 27.

 Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA et STARD group. STARD 2015: An Updated List of Essential Items for Reporting Diagnostic Accuracy Studies. Radiology 2015;277(3):826-32, doi.10.1148/radiol.2015151516

 The accuracy of cell-free fetal DNA-based non-invasive prenatal testing in singleton pregnancies: a systematic review and bivariate meta-analysis. Mackie FL, Hemming K, Allen S, Morris RK, Kilby MD. BJOG. 2017 Jan;124(1):32-46. doi: 10.1111/1471-0528.14050. Epub 2016 May 31. Review.

 When is birthweight at term (≥37 weeks' gestation) abnormally low? A systematic review and meta-analysis of the prognostic and predictive ability of current birthweight standards for childhood and adult outcomes. Malin GL, Morris RK, Riley RD, Teune MJ, Khan KS. BJOG. 2015 Apr;122(5):634-42

 Effectiveness of folic acid supplementation in pregnancy on reducing the risk of small-for-gestational age neonates: a population study, systematic review and meta-analysis. Hodgetts VA, Morris RK, Francis A, Gardosi J, Ismail KM. BJOG. 2015 Mar;122(4):478-90

 Percutaneous vesicoamniotic shunting versus conservative management for fetal lower urinary tract obstruction (PLUTO): a randomised trial. Morris RK, Malin GL, Quinlan-Jones E, Middleton LJ, Hemming K, Burke D, Daniels JP, Khan KS, Deeks J, Kilby MD; Percutaneous vesicoamniotic shunting in Lower Urinary Tract Obstruction (PLUTO) Collaborative Group. Lancet. 2013 Nov 2;382(9903):1496-506.

 Diagnostic accuracy of spot urinary protein and albumin to creatinine ratios for detection of significant proteinuria or adverse pregnancy outcome in patients with suspected pre-eclampsia: systematic review and meta-analysis. Morris RK, Riley RD, Doug M, Deeks JJ, Kilby MD. BMJ. 2012 Jul 9;345:e4342.

 Co-twin prognosis after single fetal death: a systematic review and meta-analysis. Hillman SC, Morris RK, Kilby MD. Obstet Gynecol. 2011 Oct;118(4):928-40.

View all publications in research portal